Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selonsertib Phase 2 in NASH
NCT02466516Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of selonsertib in Nonalcoholic steatohepatitis (NASH), sponsored by Gilead Sciences. Started Jun 2015; status: completed.
02
Drugs
selonsertib
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02466516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466516.